Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06372106 · ClinicalTrials.gov registry record

Project Mountain - Comparing SpO2 and SaO2 for Accuracy

A clinical trial of SpO2 and Nasal Alar Collapse, Bilateral, sponsored by Philips Clinical & Medical Affairs Global.

Recruiting
Registry status
560
Enrollment target
5
Study locations

NCT06372106 is a study of SpO2 and Nasal Alar Collapse, Bilateral that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 560 participants. The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06372106, a study of SpO2 and Nasal Alar Collapse, Bilateral, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.

RECRUITING
Registry status
560 participants
Enrollment target
5
Study locations

Study Summary

The main goal of this study is to look at the performance of the neonatal, infant, and pediatric Philips SpO2 sensors with the Philips FAST Pulse Oximetry technology. Oxygen saturation measurements (SpO2) will be obtained via pulse oximetry and invasive arterial oxygen measurements (SaO2) will be obtained via arterial blood samples as part of your clinical care and assessed by co-oximetry. The study will aim to enroll a diverse population to help us understand the impact of skin pigmentation.

Interventions

  • DEVICE SaO2 Sampling

Study Locations (5)

Arizona

  • Phoenix Children's - Phoenix

Nebraska

  • University of Nebraska Medical Center - Omaha

North Carolina

  • Duke University Medical Center - Durham

South Carolina

  • Medical University of South Carolina - Charleston

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 560 participants
Start Date 2024-04-04
Est. Completion 2025-12

What the Registry Record Tells You About NCT06372106

The ClinicalTrials.gov registry entry for NCT06372106 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 560 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with SpO2 appearing as the primary indexed condition, and to 1 intervention - of which SaO2 Sampling is the first listed.

NCT06372106 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Nebraska, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06372106 about?

NCT06372106 is a clinical study titled "Project Mountain - Comparing SpO2 and SaO2 for Accuracy". The main goal of this study is to look at the performance of the neonatal, infant, and pediatric Philips SpO2 sensors with the Philips FAST Pulse Oximetry technology. Oxygen saturation measurements (SpO2) will be obtained via pulse oximetry and invasive arterial oxygen measurements (SaO2) will be ob...

What is the current status of trial NCT06372106?

This trial is currently recruiting. The enrollment target is 560 participants. The study started on 2024-04-04. Estimated completion is 2025-12.

What conditions does trial NCT06372106 study?

This clinical trial studies the following conditions: SpO2, Nasal Alar Collapse, Bilateral, Oxygen, Measurement.

What interventions are being tested in trial NCT06372106?

The interventions under investigation include: SaO2 Sampling (DEVICE).

Who is sponsoring clinical trial NCT06372106?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06372106 being conducted?

This trial has 5 study locations across Arizona, Nebraska, North Carolina, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for SpO2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.